The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence found in ...

This guide will help you understand how NSCLC is treated, potential side effects, and how to navigate life beyond cancer.